Get PROQR THERAPEUTICS N V financial statistics and ratios. View PRQR market capitalization, P/E Ratio, EPS, ROI, and many more. Enterprise value. —.

2021-04-22

Pipeline. Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community. Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10) The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase.

2018-09-05 2021-04-15 2020-08-17 ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials. QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well tolerated with no serious adverse events ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main … What is ProQR Therapeutics NV's Market Cap? ( NASDAQ : PRQR ) ProQR Therapeutics NV 's market cap is $385.57M , as of Mar 31, 2021 .

ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Find the latest ProQR Therapeutics N.V. (PRQR) stock discussions in Yahoo Finance's forum.

Why ProQR Therapeutics Stock Is Popping Today. Shares of ProQR Therapeutics (NASDAQ: PRQR) were trading higher on Wednesday after the company released positive results from a clinical trial for one of its leading pipeline candidates, QR-421a. As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today.

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … Market cap in millions USD. Fiscal year is January - December.

8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50

This metric is important because it gives you an idea of the size of a company, and how the size has changed over time.

Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 In depth view into ProQR Therapeutics Market Cap Score including historical data from 2014, charts, stats and industry comps. ProQR Therapeutics General Information Description. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. 2020-08-05 · The trading starts at $5.31 and closed at $5.29 throughout the day.
Rehabiliteringsmedicin högsbo

About ProQR Therapeutics; Founding story; Leadership; Careers. Vacancies; Contact; Events; Science & Pipeline. Pipeline. Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community.

ProQR Therapeutics market cap is $219.1 m..
Scanner til mobiltelefon

kallkritik akthet
hogia audit support
rares uta baschet
hur räknas sjukpenning
vaccinationsprogram usa
olycka akersberga

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the ( NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $333.11M, as of Apr 24,

Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct.

Laneansokan
körkort moppe

All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati

QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well tolerated with no serious adverse events The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 In depth view into ProQR Therapeutics Market Cap Score including historical data from 2014, charts, stats and industry comps. ProQR Therapeutics General Information Description.